Learn more this winter!

Women and Bladder Cancer

A Woman-to-Woman Talk with Armine Smith, MD

Women account for almost one fourth of the more than 79,000 new cases of bladder cancer this year. Clinical gender differences have been observed but are less well described in scientific articles. Some studies show women are more likely to have advanced forms of the disease. Diagnosis and treatment options are the same, but…
Dr. Armine Smith, Director of Urologic Oncology at Sibley Memorial Hospital and Assistant Professor of Urology at Johns Hopkins University School of Medicine, will speak frankly about known and suggested differences between men and women with bladder cancer during:
· Diagnosis
· Treatment
· Survivorship



Questions and Answers about Immunotherapy and Bladder Cancer

A conversation with Jonathan Rosenberg, MD

Thu, Mar 9, 2017 3:00 PM – 4:00 PM EST

Immunotherapy is the first new treatment for bladder cancer in decades. Additional immune-based treatments are in development, but who is eligible for this treatment? Should you consider immunotherapy to treat your bladder cancer? What are the benefits? What are the risks? What should you know about this promising new treatment option?

Dr. Rosenberg will:
· describe the history of immunotherapy in bladder cancer treatment;
· explain how immunotherapies are being used to treat bladder cancer;
· identify which patients might benefit from immunotherapy;
· highlight the pros and cons of this treatment option;
· answer questions.



These Patient Insight Webinars are presented by:



Share this page:Share on FacebookTweet about this on TwitterShare on Google+Share on TumblrShare on LinkedInEmail this to someone